Explore more publications!

Health Daily South Korea Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Asian Health & Beauty Leader NutriWorks Makes TV Debut on Nationally-Aired ‘American Trends & Lifestyle’
Sterile Drug Product Testing Market Report 2025–2034: Comprehensive Insights by Towards Healthcare
Nxera Pharma to Host R&D Day 2025

Nxera Pharma to Host R&D Day 2025

NVIDIA, South Korea Government and Industrial Giants Build AI Infrastructure and Ecosystem to Fuel Korea Innovation, Industries and Jobs
Pelvic Inflammatory Disease Treatment Market to Reach USD 5.09 Billion by 2034, Driven by Rising STI Cases and Growing Awareness
Gourmet Snacks Market Size to Worth USD 147.03 Billion by 2034, Driven by Premiumization and Health-Conscious Consumers
Organoids Market to Reach USD 381.7 Million by 2034, Expanding at a Robust 18.5% CAGR | Reports Towards Healthcare
Rapid Medical Diagnostic Kits Market to Surpass USD 61.42 Billion by 2034, Driven by Expanding Healthcare Applications and Rising Health Awareness
Isobutyric Acid Market Share, Size, and Trends (2025–2032): Growing Demand in Agrochemicals and Pharmaceuticals
Pharmaceutical Market to Reach USD 3,033.21 Billion by 2034 Driven by Rising Geriatric Population
South Korea Cosmetic Packaging Market Worth USD 3.53 Bn by 2034
U.S. Cancer Biomarkers Market Set to Grow at 10.1% CAGR Driven by Early Detection, Precision Medicine, AI Integration
Companion Animal Health Market to Worth USD 61.74 Billion by 2034, Driven by Rising Pet Ownership and Humanization Trends
CDMO Services Market for Pharma and Biotech: Growth Outlook and Industry Insights (2024–2034)
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025
Implantable Medical Devices Market to Reach USD 176.33 Billion by 2034, Growing at 6.14% CAGR | Reports Towards Healthcare
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025
Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ® 25 and 50 mg
Frozen Dessert Market Size to be Worth USD 198.20 Billion by 2034, Driven by Health Trends, Innovation, and Regional Growth
Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions